Advertisement

Picture EBD Group BioPharm America 2019 Boston September 650x65px
Organisation › Details

Curetis N.V.

Founded in 2007, Curetis is a molecular diagnostics company which focuses on the development and commercialization of reliable, fast and cost-effective products for diagnosing severe infectious diseases. The diagnostic solutions of Curetis enable rapid multi-parameter pathogen and antibiotic resistance marker detection in only a few hours, a process that today can take up to days or even weeks with other techniques. To date, Curetis has raised EUR 44.3 million in an IPO on Euronext Amsterdam and Euronext Brussels and private equity funds of over EUR 63.5 million. The company is based in Holzgerlingen near Stuttgart, Germany. Curetis has signed collaboration agreements with Heraeus Medical and Cempra Inc. as well as several international distribution agreements covering many countries across Europe, the Middle East and Asia. *

 

Period Start 2015-11-01 established
  Group Curetis (Group)
  Predecessor Curetis AG
Products Industry Unyvero molecular diagnostics platform
  Industry 2 Unyvero P50™ pneumonia cartridge
Persons Person Schacht, Oliver (Curetis 201012– CEO before Epigenomics CFO)
  Person 2 Boos, Andreas (Curetis 200812– Managing Director)
     
Region Region Amsterdam
  Country Netherlands
  City n. a. Amsterdam
    Address record changed: 2015-11-15
     
Basic data Employees C: 51 to 100 (2019-04-01)
  Currency EUR
  Annual sales 1,419,000 (revenue, consolidated (2018) 2018-12-31)
  Profit -23,745,000 (2018-12-31)
  Cash 10,279,000 (2018-12-31)
     
    * Document for �About Section�: Curetis N.V.. (4/12/16). "Press Release: Curetis Publishes Full-year 2015 Financial Results and Introduces 2016 Guidance". Amsterdam & Holzgerlingen.
     
   
Record changed: 2019-07-04

Advertisement

Picture [LSUK] Life-Sciences-UK.com – The Business Web Portal 600x80px

More documents for Curetis (Group)


To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to info@iito.de and simply fill the subject line with the word »LSE Newsletter«

To get even more information, please take a look at our [gs] professional services offering and read the gene-sensor Product Flyer [PDF file]

Please visit also our web portals for the European life sciences and the worldwide mass spectrometry industry at Life-Sciences-Europe.com (European life sciences) and Mass-Spec-Capital.com (worldwide mass spectrometry)

Please visit also our web portals for the life sciences in German-speaking Europe (DE, AT & CH) and the worldwide mass spectrometry industry at Life-Sciences-Germany.com (life sciences in German-speaking Europe) and Mass-Spec-Capital.com (worldwide mass spectrometry)

Advertisement

Picture EBD Group BioPharm America 2019 Boston September 650x65px




» top